AZNAstrazeneca plc
Slide 1 of 3
Company Overview
Name
Astrazeneca plc
52W High
$90.27
52W Low
$60.82
Market Cap
$138B
Dividend Yield
1.759%
Price/earnings
4.54
P/E
4.54
Tags
Dividends
Dividends Predicted
Feb 2, 2026
$0.55 per share
Sentiment
Score
Very Bullish
81
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$63.9B
Operating Revenue
$63.9B
Total Gross Profit
$43.9B
Total Operating Income
$19.8B
Net Income
$18.1B
EV to EBITDA
$7.89
EV to Revenue
$3.06
Price to Book value
$33.26
Price to Earnings
$7.62
Additional Data
Selling, General & Admin Expense
$19.9B
Research & Development Expense
$13.6B
Other Operating Expenses / (Income)
$-123M
Total Operating Expenses
$-33.4B
Other Income / (Expense), net
$-1.7B
Total Other Income / (Expense), net
$-1.7B
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Astrazeneca plc
52W High
$90.27
52W Low
$60.82
Market Cap
$138B
Dividend Yield
1.759%
Price/earnings
4.54
P/E
4.54
Tags
Dividends
Dividends Predicted
Feb 2, 2026
$0.55 per share
Slide 2 of 5
Sentiment
Score
Very Bullish
81
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$63.9B
Operating Revenue
$63.9B
Total Gross Profit
$43.9B
Total Operating Income
$19.8B
Net Income
$18.1B
EV to EBITDA
$7.89
EV to Revenue
$3.06
Price to Book value
$33.26
Price to Earnings
$7.62
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$19.9B
Research & Development Expense
$13.6B
Other Operating Expenses / (Income)
$-123M
Total Operating Expenses
$-33.4B
Other Income / (Expense), net
$-1.7B
Total Other Income / (Expense), net
$-1.7B
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Pascal Soriot
Location
N/A, United Kingdom
Exchange
Nasdaq
Website
https://astrazeneca.com
Summary
AstraZeneca PLC focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
Company Info
CEO
Pascal Soriot
Location
N/A, United Kingdom
Exchange
Nasdaq
Website
https://astrazeneca.com
Summary
AstraZeneca PLC focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
